Linda Powers

Background

About Linda Powers

Official Northwest Biotherapeutics Corporate LinkedIn profile.Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer.The Northwest Biotherapeutics immunotherapy products are unique cancer vaccines. When compared with other active immune therapies DCVax® is more effective, longer lasting, easier to administer, can be less costly and potentially apply to all patients with the target cancers. Many experimental vaccines only apply to a limited portion of the cancer patient population and require screening of patients to determine which of them can be treated.Northwest Biotherapeutics has a deeper product pipeline, with multiple product lines and multiple target cancers already cleared for clinical trials by the FDA. The Company is unique in pursuing Europe in parallel with the US, for both our clinical trials and manufacturing.The Company’s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies.